Save your place

Sign in to WhoBought

Please try again later.

Intellia Therapeutics, Inc. (NTLA) institutional ownership

Latest close $11.38 Jul 17, 2026
Market cap$1.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
289
reported NTLA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
179 buyers · 110 sellers

Intellia Therapeutics, Inc. (NTLA) price and institutional activity

Dates

Q1 2026

$0 bought by 179 investors
Two Sigma Investments, LPBlackRock +177 more
$0 sold by 110 investors
Two Sigma Advisers, LPRenaissance Technologies LLC +108 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Intellia Therapeutics, Inc. (NTLA) institutional activity · 289

Investor Type Est. change Change Δ Own Date
Two Sigma Advisers, LP · Exited
Change −2.3M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −2.3M −100.0% Q1 2026
Two Sigma Investments, LP · Added
Change +2.0M Δ Own +74.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +2.0M +74.4% Q1 2026
BlackRock · Added
Change +1.9M Date Q1 2026
BlackRock Added· Q1 2026 +1.9M Q1 2026
UBS Group AG · Added
Change +1.8M Date Q1 2026
UBS Group AG Added· Q1 2026 +1.8M Q1 2026
Renaissance Technologies LLC Exited· Q1 2026 −1.7M −100.0% Q1 2026
Arrowstreet Capital, Limited Partnership · New
Change +1.4M Date Q1 2026
Arrowstreet Capital, Limited Partnership New· Q1 2026 +1.4M Q1 2026
Contrarius Group Holdings Ltd · Added
Change +1.2M Date Q1 2026
Contrarius Group Holdings Ltd Added· Q1 2026 +1.2M Q1 2026
Armistice Capital, LLC · Reduced
Change −820K Date Q1 2026
Armistice Capital, LLC Reduced· Q1 2026 −820K Q1 2026
Vanguard · Reduced
Change −787K Date Q1 2026
Vanguard Reduced· Q1 2026 −787K Q1 2026
Jupiter Asset Management Ltd · Added
Change +743K Date Q1 2026
Jupiter Asset Management Ltd Added· Q1 2026 +743K Q1 2026
Capital Fund Management S.A. · Added
Change +537K Date Q1 2026
Capital Fund Management S.A. Added· Q1 2026 +537K Q1 2026
State Street · Added
Change +504K Date Q1 2026
State Street Added· Q1 2026 +504K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −492K −51.8% Q1 2026
Connor, Clark & Lunn Investment Management Ltd. · Added
Change +489K Date Q1 2026
Connor, Clark & Lunn Investment Management Ltd. Added· Q1 2026 +489K Q1 2026
Royal Bank of Canada · Added
Change +426K Date Q1 2026
Royal Bank of Canada Added· Q1 2026 +426K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 289

Famous investor activity in Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics, Inc. (NTLA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Dulac Edward J. III · Officer Sell −$84K
Price $18.00 Qty −5K Owned 156K ΔOwn −2.9% Trade date Jul 2, 2026 Filed date Jul 6, 2026
Dulac Edward J. III Officer Sell $18.00 −5K −$84K 156K −2.9% Jul 2, 2026 Jul 6, 2026
Dube Michael P. · Officer Sell −$44K
Price $16.78 Qty −3K Owned 67K ΔOwn −3.8% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Dube Michael P. Officer Sell $16.78 −3K −$44K 67K −3.8% Jul 1, 2026 Jul 6, 2026
Verwiel Frank · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Verwiel Frank Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Keresty Georgia · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Keresty Georgia Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Goodman Jesse · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Goodman Jesse Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Goff Brian · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Goff Brian Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Cohen Fred E. · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Cohen Fred E. Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Chase William J. · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Chase William J. Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Bhanji Muna · Director 2 operations 22K
Owned 13K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Bhanji Muna Director 2 operations 22K 13K Jun 9, 2026 Jun 10, 2026
Basta James · Officer Sell −$17K
Price $13.78 Qty −1K Owned 157K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Basta James Officer Sell $13.78 −1K −$17K 157K Mar 2, 2026 Mar 3, 2026
Clark Eliana · Officer Sell −$8K
Price $13.78 Qty −607 Owned 94K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Clark Eliana Officer Sell $13.78 −607 −$8K 94K Mar 2, 2026 Mar 3, 2026
Leonard John M. · Director, Officer 2 operations 382K
Owned 225K Trade date Mar 1, 2026 Filed date Mar 3, 2026
Leonard John M. Director, Officer 2 operations 382K 225K Mar 1, 2026 Mar 3, 2026
Basta James · Officer 2 operations 112K
Owned 66K Trade date Mar 1, 2026 Filed date Mar 3, 2026
Basta James Officer 2 operations 112K 66K Mar 1, 2026 Mar 3, 2026
Lebwohl David · Officer 2 operations 24K
Owned 14K Trade date Mar 1, 2026 Filed date Mar 3, 2026
Lebwohl David Officer 2 operations 24K 14K Mar 1, 2026 Mar 3, 2026
Dulac Edward J. III · Officer 2 operations 149K
Owned 88K Trade date Mar 1, 2026 Filed date Mar 3, 2026
Dulac Edward J. III Officer 2 operations 149K 88K Mar 1, 2026 Mar 3, 2026
15 of 33
15 of 33 Sign in to continue to older insider transactions.

Intellia Therapeutics, Inc. (NTLA) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ark Investment Management LLC 11.4M
% of shares outstanding 12.7% Filing date Jan 29, 2024
Ark Investment Management LLC 11.4M 12.7% Jan 29, 2024
BlackRock Inc. 9.0M
% of shares outstanding 10.1% Filing date Jan 8, 2024
BlackRock Inc. 9.0M 10.1% Jan 8, 2024
Vanguard Group Inc 8.3M
% of shares outstanding 9.3% Filing date Feb 13, 2024
Vanguard Group Inc 8.3M 9.3% Feb 13, 2024
Vanguard Portfolio Management 6.3M
% of shares outstanding 5.3% Filing date Apr 29, 2026
Vanguard Portfolio Management 6.3M 5.3% Apr 29, 2026
State Street Corp
% of shares outstanding 5.3% Filing date Jan 24, 2024
State Street Corp 5.3% Jan 24, 2024
Vanguard Capital Management 5.9M
% of shares outstanding 5.0% Filing date Apr 30, 2026
Vanguard Capital Management 5.9M 5.0% Apr 30, 2026
Regeneron Pharmaceuticals, Inc. 3.7M
% of shares outstanding 5.0% Filing date Feb 11, 2022
Regeneron Pharmaceuticals, Inc. 3.7M 5.0% Feb 11, 2022
Nikko Asset Management Americas, Inc. 2.8M
% of shares outstanding 3.7% Filing date Feb 14, 2022
Nikko Asset Management Americas, Inc. 2.8M 3.7% Feb 14, 2022
8 of 10

Intellia Therapeutics, Inc. (NTLA) ownership FAQ

Who owns NTLA?

289 reporting institutions disclosed NTLA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.